Literature DB >> 20434956

Pain intensity and duration can be enhanced by prior challenge: initial evidence suggestive of a role of microglial priming.

Leah E Hains1, Lisa C Loram, Julie L Weiseler, Matthew G Frank, Erik B Bloss, Paige Sholar, Frederick R Taylor, Jacqueline A Harrison, Thomas J Martin, James C Eisenach, Steven F Maier, Linda R Watkins.   

Abstract

UNLABELLED: Activation of spinal microglia and consequent release of proinflammatory mediators facilitate pain. Under certain conditions, responses of activated microglia can become enhanced. Enhanced microglial production of proinflammatory products may result from priming (sensitization), similar to macrophage priming. We hypothesized that if spinal microglia were primed by an initial inflammatory challenge, subsequent challenges may create enhanced pain. Here, we used a "two-hit" paradigm using 2 successive challenges, which affect overlapping populations of spinal microglia, presented 2 weeks apart. Mechanical allodynia and/or activation of spinal glia were assessed. Initially, laparotomy preceded systemic lipopolysaccharide (LPS). Prior laparotomy caused prolonged microglial (not astrocyte) activation plus enhanced LPS-induced allodynia. In this "two-hit" paradigm, minocycline, a microglial activation inhibitor, significantly reduced later exaggerated pain induced by prior surgery when minocycline was administered intrathecally for 5 days starting either at the time of surgery or 5 days before LPS administration. To test generality of the priming effect, subcutaneous formalin preceded intrathecal HIV-1 gp120, which activates spinal microglia and causes robust allodynia. Prior formalin enhanced intrathecal gp120-induced allodynia, suggesting that microglial priming is not limited to laparotomy and again supporting a spinal site of action. Therefore, spinal microglial priming may increase vulnerability to pain enhancement. PERSPECTIVE: Spinal microglia may become "primed" (sensitized) following their activation by disparate forms of peripheral trauma/inflammation. As a result, such primed microglia may overrespond to subsequent challenges, thereby enhancing pain intensity and duration.
Copyright © 2010 American Pain Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20434956      PMCID: PMC2916950          DOI: 10.1016/j.jpain.2010.01.271

Source DB:  PubMed          Journal:  J Pain        ISSN: 1526-5900            Impact factor:   5.820


  48 in total

Review 1.  Chronic pain as an outcome of surgery. A review of predictive factors.

Authors:  F M Perkins; H Kehlet
Journal:  Anesthesiology       Date:  2000-10       Impact factor: 7.892

2.  Absence of detectable IL-1beta production in murine prion disease: a model of chronic neurodegeneration.

Authors:  D T Walsh; S Betmouni; V H Perry
Journal:  J Neuropathol Exp Neurol       Date:  2001-02       Impact factor: 3.685

Review 3.  Wind-up of spinal cord neurones and pain sensation: much ado about something?

Authors:  J F Herrero; J M Laird; J A López-García
Journal:  Prog Neurobiol       Date:  2000-06       Impact factor: 11.685

4.  Prior exposure to glucocorticoids sensitizes the neuroinflammatory and peripheral inflammatory responses to E. coli lipopolysaccharide.

Authors:  Matthew G Frank; Zurine D Miguel; Linda R Watkins; Steven F Maier
Journal:  Brain Behav Immun       Date:  2009-07-30       Impact factor: 7.217

5.  Intrathecal HIV-1 envelope glycoprotein gp120 induces enhanced pain states mediated by spinal cord proinflammatory cytokines.

Authors:  E D Milligan; K A O'Connor; K T Nguyen; C B Armstrong; C Twining; R P Gaykema; A Holguin; D Martin; S F Maier; L R Watkins
Journal:  J Neurosci       Date:  2001-04-15       Impact factor: 6.167

6.  A new model of sciatic inflammatory neuritis (SIN): induction of unilateral and bilateral mechanical allodynia following acute unilateral peri-sciatic immune activation in rats.

Authors:  Marucia Chacur; Erin D Milligan; Lawrence S Gazda; Charles Armstrong; Haichao Wang; Kevin J Tracey; Steven F Maier; Linda R Watkins
Journal:  Pain       Date:  2001-12       Impact factor: 6.961

7.  Repeated injury to the lumbar nerve roots produces enhanced mechanical allodynia and persistent spinal neuroinflammation.

Authors:  J L Hunt; B A Winkelstein; M D Rutkowski; J N Weinstein; J A DeLeo
Journal:  Spine (Phila Pa 1976)       Date:  2001-10-01       Impact factor: 3.468

8.  Enhanced formalin nociceptive responses following L5 nerve ligation in the rat reveals neuropathy-induced inflammatory hyperalgesia.

Authors:  Christopher J LaBuda; Renee Donahue; Perry N Fuchs
Journal:  Pain       Date:  2001-10       Impact factor: 6.961

9.  Thermal hyperalgesia and mechanical allodynia produced by intrathecal administration of the human immunodeficiency virus-1 (HIV-1) envelope glycoprotein, gp120.

Authors:  E D Milligan; K K Mehmert; J L Hinde; L O Harvey; D Martin; K J Tracey; S F Maier; L R Watkins
Journal:  Brain Res       Date:  2000-04-07       Impact factor: 3.252

10.  Transforming growth factor beta1, the dominant cytokine in murine prion disease: influence on inflammatory cytokine synthesis and alteration of vascular extracellular matrix.

Authors:  C Cunningham; D Boche; V H Perry
Journal:  Neuropathol Appl Neurobiol       Date:  2002-04       Impact factor: 8.090

View more
  38 in total

1.  Chronic inflammation and pain in a tumor necrosis factor receptor (TNFR) (p55/p75-/-) dual deficient murine model.

Authors:  Karin N Westlund; Liping Zhang; Fei Ma; Helieh S Oz
Journal:  Transl Res       Date:  2011-11-08       Impact factor: 7.012

Review 2.  Toll-like receptors in chronic pain.

Authors:  Lauren Nicotra; Lisa C Loram; Linda R Watkins; Mark R Hutchinson
Journal:  Exp Neurol       Date:  2011-10-06       Impact factor: 5.330

3.  Inflammatory 'double hit' model of temporomandibular joint disorder with elevated CCL2, CXCL9, CXCL10, RANTES and behavioural hypersensitivity in TNFR1/R2-/- mice.

Authors:  S L McIlwrath; R Nesemeier; F Ma; H S Oz; L Zhang; K N Westlund
Journal:  Eur J Pain       Date:  2017-03-20       Impact factor: 3.931

Review 4.  Idiopathic breakthrough pain: a new hypothesis.

Authors:  Alessandro Fabrizio Sabato
Journal:  Clin Drug Investig       Date:  2010       Impact factor: 2.859

5.  Morphine paradoxically prolongs neuropathic pain in rats by amplifying spinal NLRP3 inflammasome activation.

Authors:  Peter M Grace; Keith A Strand; Erika L Galer; Daniel J Urban; Xiaohui Wang; Michael V Baratta; Timothy J Fabisiak; Nathan D Anderson; Kejun Cheng; Lisa I Greene; Debra Berkelhammer; Yingning Zhang; Amanda L Ellis; Hang Hubert Yin; Serge Campeau; Kenner C Rice; Bryan L Roth; Steven F Maier; Linda R Watkins
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-31       Impact factor: 11.205

Review 6.  Mechanisms, impact and management of pain in rheumatoid arthritis.

Authors:  David A Walsh; Daniel F McWilliams
Journal:  Nat Rev Rheumatol       Date:  2014-05-27       Impact factor: 20.543

Review 7.  Neuroinflammation and Central Sensitization in Chronic and Widespread Pain.

Authors:  Ru-Rong Ji; Andrea Nackley; Yul Huh; Niccolò Terrando; William Maixner
Journal:  Anesthesiology       Date:  2018-08       Impact factor: 7.892

8.  Pain in the Developing Brain: Early Life Factors Alter Nociception and Neurobiological Function in Adolescent Rats.

Authors:  Sabrina Salberg; Glenn R Yamakawa; Yannick Griep; Jesse Bain; Jaimie K Beveridge; Mujun Sun; Stuart J McDonald; Sandy R Shultz; Rhys D Brady; David K Wright; Melanie Noel; Richelle Mychasiuk
Journal:  Cereb Cortex Commun       Date:  2021-02-24

9.  Prior exposure to repeated morphine potentiates mechanical allodynia induced by peripheral inflammation and neuropathy.

Authors:  Lisa C Loram; Peter M Grace; Keith A Strand; Frederick R Taylor; Amanda Ellis; Debra Berkelhammer; Melissa Bowlin; Bryce Skarda; Steven F Maier; Linda R Watkins
Journal:  Brain Behav Immun       Date:  2012-08-10       Impact factor: 7.217

Review 10.  Pathological pain and the neuroimmune interface.

Authors:  Peter M Grace; Mark R Hutchinson; Steven F Maier; Linda R Watkins
Journal:  Nat Rev Immunol       Date:  2014-02-28       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.